Photo and Redox Dual Responsive Reversibly Cross-Linked Nanocarrier for Efficient Tumor-Targeted Drug Delivery
Source abstract
Abstract
To develop a feasible and efficient nanocarrier for potential clinical application, a series of photo and redox dual responsive reversibly cross-linked micelles have been developed for the targeted anticancer drug delivery. The nanocarrier can be cross-linked efficiently via a clean, efficient, and controllable coumarin photodimerization within the nanocarrier, which simplify the formulation process and quality control prior clinical use and improve the in vivo stability for tumor targeting. At the same time, cross-linking of nanocarrier could be cleaved via the responsiveness of the built-in disulfide cross-linkage to the redox tumor microenvironment for on-demand drug release. Coumarin and disulfide bond was introduced into a linear-dendritic copolymer (named as telodendrimer) precisely via peptide chemistry. The engineered nanocarrier possesses good drug loading capacity and stability, and exhibits a safer profile as well as similar anticancer effects compared with free drug in cell culture. The in vivo and ex vivo small animal imaging revealed the preferred tumor accumulation and the prolonged tumor residency of the payload delivered by the cross-linked micelles compared to the non-cross-linked micelles and free drug surrogate because of the increased stability.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Education and Critical Thinking Development · Education Systems and Policy · Education, Achievement, and Giftedness
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacology, SUNY Upstate Cancer Research Institute, State University of New York Upstate Medical University, Syracuse, New York 13210, United States
Department of Applied Chemistry, College of Science, China Agricultural University, Beijing, 100193, China
Funding
NIH Office of the Director
References (47)
Show source-provided references
1. Davis M. E. · Nat. Rev. Drug Discovery · 2008 · 9 · 77110.1038/nrd2614 ↗
2. Peer D. · Nat. Nanotechnol. · 2007 · 12 · 75110.1038/nnano.2007.387 ↗
3. Shi J. · Acc. Chem. Res. · 2011 · 10 · 112310.1021/ar200054n ↗
4. Zhang L. · Clin. Pharmacol. Ther. · 2008 · 5 · 76110.1038/sj.clpt.6100400 ↗
5. Kedar U. · Nanomedicine (N. Y., NY, U. S.) · 2010 · 6 · 714
6. Yokoyama M. · Expert Opin. Drug Delivery · 2010 · 2 · 14510.1517/17425240903436479 ↗
7. Hobbs S. K. · Proc. Natl. Acad. Sci. U. S. A. · 1998 · 8 · 460710.1073/pnas.95.8.4607 ↗
8. Maeda H. · J. Controlled Release · 2000 · 1 · 27110.1016/S0168-3659(99)00248-5 ↗
9. Jain R. K. · Nat. Rev. Clin. Oncol. · 2010 · 11 · 65310.1038/nrclinonc.2010.139 ↗
10. Wei A. · J. Controlled Release · 2012 · 2 · 23610.1016/j.jconrel.2012.10.007 ↗
11. Shao Y. · Ther. Delivery · 2012 · 12 · 140910.4155/tde.12.106 ↗
12. Shuai X. · Bioconjugate Chem. · 2004 · 3 · 44110.1021/bc034113u ↗
13. Zhang L. · Biomacromolecules · 2007 · 9 · 289010.1021/bm070370g ↗
14. Xu X. · Macromolecules · 2008 · 22 · 842910.1021/ma801725w ↗
15. Huang H. · J. Am. Chem. Soc. · 1999 · 15 · 380510.1021/ja983610w ↗
16. Huang H. · Macromolecules · 2001 · 3 · 54710.1021/ma001003z ↗
17. Cajot S. · J. Controlled Release · 2011 · 1 · 3010.1016/j.jconrel.2011.03.026 ↗
18. Zhang S. · J. Am. Chem. Soc. · 2010 · 31 · 1064210.1021/ja103391k ↗
19. Koo A. N. · Chem. Commun. · 2008 · 48 · 657010.1039/b815918a ↗
20. Kato J. · Mol. Pharmaceutics · 2012 · 6 · 172710.1021/mp300128b ↗
21. Li Y. · Biomaterials · 2011 · 27 · 663310.1016/j.biomaterials.2011.05.050 ↗
22. Li Y. · Angew. Chem., Int. Ed. · 2012 · 12 · 286410.1002/anie.201107144 ↗
23. Zhao Y. · J. Mater. Chem. · 2009 · 28 · 488710.1039/b819968j ↗
24. Zhao Y. · Macromolecules · 2012 · 9 · 364710.1021/ma300094t ↗
25. Gohy J. F. · Chem. Soc. Rev. · 2013 · 17 · 711710.1039/c3cs35469e ↗
26. Jiang J. · Macromolecules · 2007 · 4 · 79010.1021/ma062493j ↗
27. Kumar S. · J. Mater. Chem. · 2012 · 15 · 725210.1039/c2jm16380b ↗
28. Yan B. · J. Am. Chem. Soc. · 2011 · 49 · 1971410.1021/ja209793b ↗
29. Cheng R. · Biomaterials · 2013 · 14 · 364710.1016/j.biomaterials.2013.01.084 ↗
30. Raghupathi K. R. · Chem. - Eur. J. · 2011 · 42 · 1175210.1002/chem.201101066 ↗
31. Yesilyurt V. · Angew. Chem., Int. Ed. · 2011 · 13 · 303810.1002/anie.201006193 ↗
32. Fairbanks B. D. · Macromolecules · 2011 · 8 · 244410.1021/ma200202w ↗
33. Scott T. F. · Science · 2005 · 5728 · 161510.1126/science.1110505 ↗
34. Han D. · Langmuir · 2012 · 5 · 232710.1021/la204930n ↗
35. Xuan J. · Langmuir · 2014 · 30 · 41010.1021/la404493n ↗
36. Baek H. G. · J. Comb. Chem. · 2009 · 1 · 9110.1021/cc800092y ↗
37. Luo J. · Bioconjugate Chem. · 2010 · 7 · 121610.1021/bc1000033 ↗
38. Huang W. · Chem. Commun. · 2013 · 59 · 667410.1039/c3cc43209b ↗
39. Xiao K. · Biomaterials · 2009 · 30 · 600610.1016/j.biomaterials.2009.07.015 ↗
40. Xiao K. · Biomaterials · 2011 · 13 · 343510.1016/j.biomaterials.2011.01.021 ↗
41. Xiao K. · Cancer Res. · 2012 · 8 · 210010.1158/0008-5472.CAN-11-3883 ↗
42. He J. · Soft Matter · 2009 · 2 · 30810.1039/B814278E ↗
43. Trenor S. R. · Chem. Rev. · 2004 · 6 · 305910.1021/cr030037c ↗
44. Chen Y. · J. Polym. Sci., Part A: Polym. Chem. · 1995 · 16 · 270510.1002/pola.1995.080331604 ↗
45. Britten R. A. · Int. J. Radiat. Oncol. Biol. Phys. · 1992 · 3 · 52710.1016/0360-3016(92)91069-Y ↗
46. Balendiran G. K. · Cell. Biochem. Funct. · 2004 · 6 · 34310.1002/cbf.1149 ↗
47. Bastiat G. · J. Controlled Release · 2013 · 3 · 33410.1016/j.jconrel.2013.06.014 ↗